Analysts Set Trupanion, Inc. (NASDAQ:TRUP) Target Price at $46.60

Shares of Trupanion, Inc. (NASDAQ:TRUP) have received a consensus rating of “Moderate Buy” from the seven ratings firms that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $46.60.

TRUP has been the subject of a number of analyst reports. Piper Sandler cut their price objective on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research report on Thursday, February 20th. Stifel Nicolaus lowered their price objective on Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a research report on Thursday, February 20th.

Trupanion Stock Up 0.3 %

TRUP stock opened at $37.90 on Monday. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. The company’s 50 day simple moving average is $41.23 and its 200-day simple moving average is $46.61. Trupanion has a 12 month low of $19.69 and a 12 month high of $57.90. The firm has a market capitalization of $1.61 billion, a PE ratio of -164.78, a P/E/G ratio of 6.02 and a beta of 1.70.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The company had revenue of $337.31 million during the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. Equities analysts expect that Trupanion will post 0.13 earnings per share for the current fiscal year.

Insider Transactions at Trupanion

In other Trupanion news, CFO Fawwad Qureshi sold 1,373 shares of the business’s stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total transaction of $46,984.06. Following the transaction, the chief financial officer now owns 2,416 shares in the company, valued at $82,675.52. The trade was a 36.24 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Margaret Tooth sold 2,294 shares of the business’s stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total value of $72,008.66. Following the transaction, the chief executive officer now directly owns 118,784 shares in the company, valued at $3,728,629.76. This trade represents a 1.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 29,984 shares of company stock worth $999,042. 5.50% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Trupanion

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. FMR LLC lifted its stake in shares of Trupanion by 55,963.7% in the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock worth $49,213,000 after acquiring an additional 1,170,202 shares in the last quarter. Balyasny Asset Management L.P. grew its position in shares of Trupanion by 368.2% during the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider’s stock worth $40,548,000 after buying an additional 661,559 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in Trupanion by 170.7% in the fourth quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider’s stock valued at $16,248,000 after acquiring an additional 212,545 shares in the last quarter. Freestone Grove Partners LP bought a new position in Trupanion during the 4th quarter valued at $7,776,000. Finally, Baillie Gifford & Co. grew its holdings in Trupanion by 26.6% during the 4th quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock worth $33,806,000 after acquiring an additional 147,341 shares in the last quarter.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.